T cell immunotherapy: Promising results in children and adults with leukemia

Nearly 90 percent of children and adults with a highly aggressive form of acute lymphoblastic leukemia showed no evidence of cancer after receiving a novel, personalized cell therapy that reprograms a patient’s immune system. In pilot studies of bioengineered T cells that attack leukemia, 24 of 27 patients experienced complete responses within 28 days after treatment.

Fuente : http://www.eurekalert.org/pub_releases/2013-12/cho…